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Abstract 
Objective: The study aims to evaluate the 
association between Body Mass Index (BMI), 
gestational weight gain (GWG) and adverse 
obstetric outcomes among primigravidas. 
Material and methods: This was a prospective 
cohort study conducted at a tertiary University 
Hospital between June 2015 and May 2017. The 
study included 480 primigravidas, with singleton 
pregnancies, who were divided into three 
groups: women with a healthy weight (BMI: 
18.5–24.9 kg/m2) overweight (BMI: 25 – 29.9 
kg/m2) and obese (BMI ≥ 30 kg/m2). The primary 
outcome of the study was the rate of GWG in 
the participants. Secondary outcomes included 
the rate of gestational diabetes mellitus (GDM), 
gestational hypertension, pre-eclampsia, 
preterm labor (PTL), postdate pregnancy, fetal 
macrosomia and the rate of birth by cesarean 
(CB).  
Results: There were no significant differences 
between groups regarding the socio-
demographic criteria. The rate of GWG was 
significantly higher in obese women versus 
average weight women (11.4±1.73 vs. 
10.49±1.09, p=0.0001). There was an increased 
incidence of GDM (p=0.008), gestational 
hypertension (p=0.001), pre-eclampsia 
(p=0.0001), PTL (p=0.002), postdate (p=0.0001) 
and macrosomia (p=0.0001) in women who 
were obese compared with women with a 
healthy weight. Additionally, there was an 
increased incidence of CB with increasing body 
mass (p=0.0001)  
Conclusions: Higher BMI in primigravidas is 
associated with increased GWG and with 
adverse pregnancy outcomes such as GDM, 
gestational hypertension, pre-eclampsia, PTL, 
postdate, fetal macrosomia and cesarean birth. 
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Introduction 
Overweight and obesity are defined as 
abnormal or excessive percent fat 
accumulation that may impair health.1 
The WHO and the National Institute of 
Health define underweight as a body 
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mass index (BMI) of ≤18.5, normal 
weight as a BMI of 18.5–24.9, 
overweight as a BMI of 25–29.9, and 
obesity as a BMI of ≥30. Obesity is 
further characterized by BMI into class I 
(30–34.9), class II (35–39.9), and class 
III (>40).1 The WHO estimates that in 
2008 around 1.4 billion adults were 
overweight. Additionally, they stated that 
in 2015 nearly 2.3 billion adults were 
overweight and >700 million were 
obese.2 
There is no accepted definition for 
obesity during pregnancy due to the 
expected weight gain variability during 
pregnancy and the short interval of time. 
Therefore, it is strongly recommended 
that pregnant women have their BMI 
calculated at the first antenatal visit, 
which is usually in the first trimester, 
with recommendations then made for 
healthy gestational weight gain. Some 
studies use other measures to define 
obesity including weight at delivery and 
the waist to hip ratio.3 
Maternal obesity is known to be 
associated with maternal complications 
including gestational diabetes mellitus 
(GDM), gestational hypertension and 
preeclampsia.4-6 Large-for-gestational-
age infants and cesarean delivery (CB) 
are also more common in women who 
are overweight or obese.7  
The purpose of the current study was to 
evaluate the association between BMI, 
gestational weight gain (GWG) and 
obstetric outcomes in primigravid 
women delivering singleton babies. 
Materials and methods  
This study was a prospective cohort 
study conducted at Aswan University 
Hospital, Egypt, between June 2015 and 
May 2017. The Institutional Ethical 
Review Board approved the study 
protocol (IRB009898). We included all 
singleton pregnancies greater than 20 
weeks in gestational age (GA) from the 
Outpatient Antenatal Care Clinic.  
We excluded women with a risk of 
preterm delivery (before 37 weeks of 
gestation), those with medical disorders 
during pregnancy (hypertension, 
diabetes, cardiac disease), those with a 
history of infertility treatment (no 
pregnancy for more than one year), 
women who received medications, and 
those who are participating in dietary 
control and exercises prior to and during 
pregnancy to control their body weight. 
We obtained a written informed consent 
from all women before participation after 
discussing the nature of the study. First, 
the participating women were enrolled in 
the screening phase of the study. This 
phase included a history (personal, 
menstrual and obstetric) taking, 
including parity and gestational age. 
Gestational age was calculated based 
on a reliable first day of the last 
menstrual period or if unknown dating 
based on a first trimester ultrasound 
(US). We measured the weight and 
height of each woman and calculated 
the BMI in the clinic by a nurse. 
Additionally, a fasting blood glucose was 
done at inclusion to exclude Diabetes 
Mellitus (DM) and blood pressure 
measurement to exclude the presence 
of essential hypertension.  
The eligible women were allocated to 
either Group I (healthy weight), Group II 
(over weight), and Group III (obese) 
according to BMI. All of the women were 
monitored throughout their routine 
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antenatal pathway until birth for 
assessment of any antenatal adverse 
outcomes. Birthing was encouraged to 
be within the institution birthing unit to 
enable final evaluation of the study 
outcomes as some women in our 
locality could give birth at home due to 
transfer difficulties or illiteracy. 
The primary outcome of the study was 
the rate of GWG in the three groups. 
Secondary outcomes included the rate 
of GDM, gestational hypertension, 
preeclampsia, preterm labor (PTL <37 
weeks of gestation), premature rupture 
of membranes (PROM), postdate 
pregnancy (pregnancy > 40 weeks 
gestation), fetal macrosomia (>4.5 kg), 
excessive maternal weight gain (>11.5 
kg), and the rate of birth by cesarean.  
Data were entered and statistically 
analyzed using the Statistical Package 
for Social Sciences (SPSS) version 22. 
Qualitative data were described as 
numbers and percentages. Chi-Square 
test was used for comparison between 
groups. Quantitative data were 
described as mean (SD) after testing for 
normality by Kolmogorov-Smirnov test. 
One-way ANOVA test was used for 
comparison between groups. Student's 
T-test was used to compare between 
each 2 groups. P-value ≤0.05 was 
considered to be statistically significant.
 
Table 1: Characteristics of the study participants at the first antenatal visit. 
 
Variables # 
Average weight 
(n = 180) 
Overweight 
(n = 180) 
Obese 
(n = 120) 
 
p-value 
Age (year) 25.24 ± 2.2 25.24 ± 2.6 25.78 ± 2.8 0.119 
Height (cm) 163.82 ± 2.58 163.94 ± 28 163.49 ± 2.3 0.327 
Weight (kg) 60.76± 2.23 74.12 ± 2.56 89.0 ± 3.18 0.0001* 
BMI (kg/m2) 22.65 ± 1. 1 27.57 ± 1.02 33.28 ± 0.82 0.0001* 
Gestational age at inclusion 
(weeks) 
22.55 ± 1.2 22.87 ± 1.6 23.05 ± 1.3 0.245 
SBP 108.58 ± 9.16 108.25 ± 5.08 108.62 ± 1.01 0.901 
DBP 67.25 ± 6.44 66.58 ± 7.76 67.08 ± 6.4 0.645 
FBG 76.98 ± 7 77.09 ± 4.39 77.43 ± 4.68 0.779 
BMI, Body Mass Index; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; FBG, Fasting 
Blood Glucose.  
# All Variables are presented as mean ± standard deviation. 
* Statistical Significant Difference between all groups tested by ANOVA test.  
 
Results 
Our study approached 700 eligible 
pregnant women to participate; 220 
(31.4%) were excluded as they did not 
meet our inclusion criteria or did not 
complete antenatal care at the hospital. 
The remaining 480 women were divided 
into three groups according to their BMI. 
Group I included 180 (37.5%) women 
with a healthy weight (22.65±1.1), group 
II included 180 (37.5%) women who 
were overweight (27.57±1.02), and 
group III included 120 (25%) obese 
women (33.28±0.82). Their 
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sociodemographic and baseline 
characteristics are shown in Table 1. 
Maternal age, gestational age at 
inclusion, systolic blood pressure, 
diastolic blood pressure and fasting 
blood sugar at first visit in our obstetric 
clinic showed no significant differences. 
No cases of passive smoking in all 
groups. 
Gestational weight gain showed a 
statistically significant difference 
between women with a healthy weight 
and those who were overweight and 
obese (p= 0.0001). There were 
increased incidence of GDM (p=0.008), 
gestational hypertension (p=0.001), PTL 
(p=0.0001), PROM (p=0.002), postdate 
(p=0.0001) and fetal macrosomia 
(p=0.0001) in women who were obese 
compared with women with a healthy 
weight. 
Table 2: Adverse perinatal outcomes by body mass index groups 
Outcomes # Average weight 
(n = 180) 
Overweight 
(n = 180) 
Obese 
(n = 120) 
p-value 
GDM 5 (2.8) 9 (5) 12 (10) 0.024* 
0.276 / 0.008*** / 0.96 
Gestational 
hypertension 
5 (2.8) 12 (6.7) 15 (12.5) 0.004* 
0.082 / 0.001*** / 0.84 
Pre-eclampsia 1 (0.6) 8 (4.4) 11 (9.2) 0.001* 
0.037** / 0.0001*** / 0. 1 
PTL 4 (2.2) 12 (6.7) 13 (10.8) 0.008* 
0.041** / 0.002*** / 0.201 
PROM 3 (1.7) 9 (5) 14 (11.7) 0.001* 
0.078 / 0.0001*** / 0.033**** 
Postdate 4 (2.2) 17 (9.4) 18 (15) 0.001* 
0.003** / 0.0001*** / 0.142 
Macrosomia 1 (0.6) 9 (5) 14 (11.7) 0.0001* 
0.01** / 0.0001*** / 0.033**** 
GDM, Gestational diabetes mellitus; PTL, Preterm Labor; PROM, Premature Rupture of Membranes. 
# All Variables are presented as number (percentage). 
*Statistical significant difference between all groups tested by ANOVA test.  
**Statistical significant difference between average weight and overweight group tested by Student's T-
test.  
***Statistical significant difference between average weight and obese group tested by Student's T-test.  
****Statistical significant difference between overweight and obese group tested by Student's T-test 
 
There were increased incidence of 
preeclampsia (p=0.037), PTL (p=0.04), 
postdate (p=0.003) and macrosomia 
(p=0.01) in overweight women than 
average weight women. However, no 
significant difference in GDM, 
gestational hypertension and postdate 
(p=0.276, p=0.082, and p=0.078 
respectively). 
The incidence of PROM and 
macrosomia were increased in obese 
women compared with overweight 
women (p=0.033).However no 
significant difference in GDM (p=0.96), 
gestational hypertension (p=0.84), 
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preeclampsia (p=0.1), PTL (p=0.201) 
and postdate (p=0.142) (Table 2) 
between overweight and obese women 
was shown in analysis. 
Finally, there was an increased 
incidence of birth by cesarean with 
increasing BMI (15.6 %) in women with 
healthy weight, (31.1%) in women who 
were overweight and (58.3%) obese 
(p=0.0001) (Table 3). 
Table 3: Gestational weight gain, excessive weight gain and Mode of birth in the 
three groups. 
Outcomes # Average weight 
(n = 180) 
Overweight 
(n = 180) 
Obese 
(n = 120) 
p-value 
 
Gestation Weight 
gain 
 
10.49 ± 1.09  10.86 ± 1.36  11.4 ± 1.73  0.0001* 
0.0001** / 0.0001*** / 0.0001**** 
 
Excessive GWG 
outside the IOM 
recommendations 
 
 
 
18 (10) 
 
 
47 (26) 
 
 
49 (40) 
 
 
0.0001* 
0.0001** / 0.0001*** / 0.007**** 
Mode of Birth     
- CB 28 (15.6) 56 (31.1) 70 (58.3)  
0.0001* 
0.0001** / 0.0001***/ 0.0001**** - VD 152 (84.4) 124 (68.9) 50 (41.7) 
 
CB, Cesarean Delivery; VD, Vaginal Delivery. 
# All Variables are presented either mean and standard deviation or number (percentage). 
*Statistical significant difference between all groups tested by ANOVA test.  
**Statistical significant difference between average weight and overweight group tested by Student's T-
test.  
***Statistical significant difference between average weight and obese group tested by Student's T-test.  
****Statistical significant difference between overweight and obese group tested by Student's T-test 
 
Discussion 
The study found a significant 
association between increasing 
maternal BMI and the risk of developing 
GDM, preeclampsia, gestational 
hypertension, PTL, PROM, postdate, 
fetal macrosomia and birth by cesarean. 
This is consistent with other research 
though we present a unique focus on 
Egyptian mothers. 
Several observational studies 
demonstrated an association between 
maternal obesity and gestational 
hypertension, with a reported 2.5-3.2-
fold increased risk.7,8 A link has also 
been drawn between maternal obesity 
and preeclampsia.9 One systematic 
review found the risk of preeclampsia 
doubled with each increase of 5 to 7 
kg/m2 in BMI.10 In another prospective 
cohort study, increases in BMI between 
the first and second pregnancies were 
found to also increase pre-eclampsia 
risk.11 Our results are keeping in the 
same track with all previous studies; 
however, it is the first one among 
Egyptian mothers. The incidence of 
gestational hypertension and pre-
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eclampsia was significantly higher 
among women who are obese than 
women with a healthy weight (12.5% vs 
2.8% and 9.2% vs 0.6% respectively) 
In our study, the incidence of GDM has 
been shown to be higher in obese and 
overweight women, with a rate of 10% 
and 5% respectively compared with 
2.8% in average weight women. 
Previous studies have shown an 
association between maternal obesity 
and an increased risk of GDM.7,8 A 
meta-analysis found that the overall risk 
for GDM in obese patients was 3.76 
times higher than in non-obese patients 
(OR=3.31–4.28), with the prevalence of 
GDM increasing by 0.82% for every 
increase of 1 kg/m2 in BMI.12  
Maternal obesity predisposes to insulin 
resistance, many women who are obese 
will have undiagnosed preexisting type 2 
diabetes mellitus before pregnancy.13 
Several studies have described the 
detrimental effect of increasing maternal 
obesity on perinatal outcomes in women 
with diabetes. Sugiyama et al., 2014, 
evaluated women in Japan with 
gestational diabetes finding increased 
rates of adverse pregnancy outcomes 
with increasing BMI.14 Similarly, 
Marshall et al., 2014, in the United 
States demonstrated that increasing 
BMI among diabetic gravidas increased 
rates of preeclampsia, macrosomia, and 
cesarean section.15 
In our study, the incidence of PTL has 
been shown to be higher in obese and 
overweight women, with a rate of 13% 
and 12% respectively compared with 
4% in average weight women. Overall, 
the literature is conflicting regarding the 
association between preterm delivery 
and obesity. Although some studies 
support an increased risk4 others do 
not16 particularly when controlling for 
confounding co-morbidities including 
hypertensive disorders, DM and 
smoking.17,18 
In our study, the incidence of postdate 
has been shown to be higher in obese 
and overweight women, with a rate of 
15% and 9.4% respectively compared 
with 2.2% in average weight women. 
Obesity has been associated with 
prolonged and post term pregnancy, 
with several studies demonstrating an 
increased risk of prolonged pregnancy 
beyond 41 weeks’ gestation as well as 
post term pregnancy at or beyond 42 
weeks’ gestation among obese 
women.16,19 
Fetal macrosomia was higher in obese 
and overweight women, with a rate of 
11.7% and 5% respectively compared 
with 0.6% in average weight women. 
Obesity is a well-established risk factor 
for fetal macrosomia with a 2-3 fold 
increased risk.7,16 Morbid obesity and 
increasing BMI have been shown to be 
associated with higher rates of 
macrosomia.9,16 
In our study CB has been shown to be 
higher in obese and overweight women, 
with a rate of 58.3% and 31.1% 
respectively compared with 15.6% in 
average weight women. This is in 
agreement with studies that have been 
shown an increased risk of CB among 
obese women.4,8 
The current study had some limitations. 
The ideal time to record the baseline 
height and weight of a pregnant woman 
is prior to pregnancy or in the very early 
antenatal period. In Egypt this is seldom 
a routine practice. Systems in the 
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hospital are not structured to provide 
adequate booking data. A strength is 
that we measured height and weight in 
early pregnancy before any real impact 
of GWG. 
In conclusion, increased maternal BMI 
in primigravidas is associated with 
increased GWG and adverse pregnancy 
outcomes. 
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